Hematological and biological factors.
Conditions
Interventions
Intervention 1: Intervention group: Receiving Darcocephalum kotschyi capsule (50mg) orally three times daily for 4 weeks. Dracocephalum capsule are made in Dr Bahri pharmaceutical company (Isfahan) an
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Healthy volunteers Male
Exclusion criteria
Exclusion criteria: Females Volunteers on drug treatment (any drugs, herbal or chemical) Non healthy subjects (any disease diagnosed by physician and blood analysis) Children (under 18) and old subjects (above 50) Smoking subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete blood cell counting. Timepoint: At the beginning of study and 28 days after consumption of Zaringiah capsule. Method of measurement: Device K-1000 Hematology Analyzer.;Blood biochemical factors. Timepoint: At the beginning of study and 28 days after consumption of Zaringiah capsule. Method of measurement: Spectrophotometry technique.;Blood parameters for hepatic and renal function. Timepoint: At the beginning of study and 28 days after consumption of Zaringiah capsule. Method of measurement: Colorimetric/fluorometric assay. | — |
Secondary
| Measure | Time frame |
|---|---|
| General physical condition. Timepoint: Daily for 28 days. Method of measurement: Questioning and if necessary clinical examination.;Central nervous system effects including sleep and sedativety. Timepoint: Daily for 28 days. Method of measurement: Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hassan Sadraei
Esfahan University of Medical Sciences
Outcome results
None listed